Form D — Allotera Therapeutics, Inc.
0001874298-25-000004 · filed Sep 8, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $163,043,971
- Reported amount sold
- $109,493,339
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Allotera Therapeutics, Inc.
- CIK
- 1874298
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4260 FOREST PARK AVE., SUITE 100
ST. LOUIS, MO 63110 - Phone
- 314-501-1968
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Niall O'Donnell · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Bali Muralidhar · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Peter Kiener · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Drew Dennison · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Kevin Li · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Bosun Hau · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Matthew Cooper · Executive OfficerSt. Louis, MO Find on LinkedIn ↗
-
Ayman Kabakibi · Executive OfficerSt. Louis, MO Find on LinkedIn ↗
-
Keith Vendola · Executive OfficerSt. Louis, MO Find on LinkedIn ↗
-
Natalie Mount · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Kumar Srinivasan · Executive OfficerSt. Louis, MO Find on LinkedIn ↗
-
Cherry Thomas · Executive OfficerSt. Louis, MO Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗